Literature DB >> 21979320

[Treat-to-target from the patient perspective].

E Gromnica-Ihle1, M Rink.   

Abstract

The international treat-to-target initiative including rheumatoid arthritis (RA) patients has defined remission or alternatively low disease activity as treatment goals. In Germany representatives of the medical profession, such as doctors, nurses and including the Deutsche Rheuma-Liga, are deliberating how to adapt and realize these goals in practice. The patient's perspective has to be taken into consideration as an outcome variable. Until now no combined patient reported outcome (PRO) score exists which is generally accepted by the scientific community and which puts the patient's perspective as the main primary outcome.Patients and doctors ought to decide jointly about the therapy goal remission/low disease activity and about other PROs and the planned strategy to achieve these goals. A precondition is that a sufficient timeframe is still available for this. The joint target of the medical profession and the Deutsche Rheuma-Liga is 1 rheumatologist per 50,000 adult inhabitants. An interdisciplinary and multidisciplinary treatment of RA patients is just as imperative as the expansion of patient training, information and self-management programs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979320     DOI: 10.1007/s00393-011-0773-y

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  27 in total

1.  Are physician-derived joint counts obsolete?

Authors:  Edward C Keystone
Journal:  J Rheumatol       Date:  2010-05       Impact factor: 4.666

2.  'I'm hurting, I want to kill myself': rheumatoid arthritis flare is more than a high joint count--an international patient perspective on flare where medical help is sought.

Authors:  Sarah Hewlett; Tessa Sanderson; James May; Rieke Alten; Clifton O Bingham; Marita Cross; Lyn March; Christof Pohl; Thasia Woodworth; Susan J Bartlett
Journal:  Rheumatology (Oxford)       Date:  2011-05-12       Impact factor: 7.580

3.  Rheumatology outcomes: the patient's perspective.

Authors:  Alison Carr; Sarah Hewlett; Rod Hughes; Helene Mitchell; Sarah Ryan; Maggie Carr; John Kirwan
Journal:  J Rheumatol       Date:  2003-04       Impact factor: 4.666

4.  The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study.

Authors:  E M Barrett; D G Scott; N J Wiles; D P Symmons
Journal:  Rheumatology (Oxford)       Date:  2000-12       Impact factor: 7.580

5.  Patient-derived joint counts are a potential alternative for determining Disease Activity Score.

Authors:  Arthur Kavanaugh; Susan J Lee; Haoling H Weng; Yun Chon; Xing-Yue Huang; Shao-Lee Lin
Journal:  J Rheumatol       Date:  2010-02-15       Impact factor: 4.666

6.  Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population.

Authors:  T Sokka; A Häkkinen; E Krishnan; P Hannonen
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

7.  Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative.

Authors:  L Gossec; M Dougados; N Rincheval; A Balanescu; D T Boumpas; S Canadelo; L Carmona; J-P Daurès; M de Wit; B A C Dijkmans; M Englbrecht; Z Gunendi; T Heiberg; J R Kirwan; E M Mola; M Matucci-Cerinic; K Otsa; G Schett; T Sokka; G A Wells; G J Aanerud; A Celano; A Dudkin; C Hernandez; K Koutsogianni; F N Akca; A-M Petre; P Richards; M Scholte-Voshaar; G Von Krause; T K Kvien
Journal:  Ann Rheum Dis       Date:  2008-12-03       Impact factor: 19.103

8.  Patient decision-making related to antirheumatic drugs in rheumatoid arthritis: the importance of patient trust of physician.

Authors:  Richard W Martin; Andrew J Head; Jonathan René; Timothy J Swartz; Justus J Fiechtner; Barbara A McIntosh; Margaret Holmes-Rovner
Journal:  J Rheumatol       Date:  2008-02-15       Impact factor: 4.666

9.  Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9.

Authors:  John R Kirwan; Stanton Newman; Peter S Tugwell; George A Wells; Sarah Hewlett; Leanne Idzera; Britta Laslo; Lyn M March; Patricia Minnock; Pam Montie; Jo Nicklin; Tamara Rader; Pamela Richards; Tessa C Sanderson; Maria Suarez-Almazor; Elizabeth Tanjong-Ghogomu; Erin Ueffing; Vivian Welch
Journal:  J Rheumatol       Date:  2009-09       Impact factor: 4.666

10.  Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis.

Authors:  L H D van Tuyl; A M C Plass; W F Lems; A E Voskuyl; P J S M Kerstens; B A C Dijkmans; M Boers
Journal:  Rheumatology (Oxford)       Date:  2008-08-18       Impact factor: 7.580

View more
  5 in total

Review 1.  [Treat to target and personalized medicine (precision medicine)].

Authors:  J Detert; G R Burmester
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

2.  Quality of care of rural rheumatoid arthritis patients in Austria.

Authors:  Rudolf Puchner; Hans Peter Brezinschek; Manfred Herold; Thomas Nothnagl; Andrea Studnicka-Benke; Josef Fritz; Burkhard F Leeb
Journal:  Wien Klin Wochenschr       Date:  2014-03-28       Impact factor: 1.704

3.  [Treat to participation : Position paper of the German Society for Rheumatology on sustained improvement of functional health of patients with rheumatic and musculoskeletal diseases].

Authors:  W Mau; W Beyer; I Ehlebracht-König; J-M Engel; E Genth; U Lange
Journal:  Z Rheumatol       Date:  2015-08       Impact factor: 1.372

4.  Comparative effectiveness of adalimumab and etanercept for rheumatoid arthritis in the Brazilian Public Health System.

Authors:  Jéssica Barreto Ribeiro Dos Santos; Alessandra Maciel Almeida; Francisco de Assis Acurcio; Haliton Alves de Oliveira Junior; Adriana Maria Kakehasi; Augusto Afonso Guerra Junior; Marion Bennie; Brian Godman; Juliana Alvares
Journal:  J Comp Eff Res       Date:  2016-09-19       Impact factor: 1.744

5.  Is the state of health of rheumatoid arthritis patients receiving adequate treatment, predictable? - Results of a survey.

Authors:  Rudolf Puchner; Hans Peter Brezinschek; Josef Fritz; Manfred Herold; Monika Mustak; Thomas Nothnagl; Stephan E Puchner; Andrea Studnicka-Benke; Burkhard F Leeb
Journal:  BMC Musculoskelet Disord       Date:  2015-05-06       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.